US 8143445
HDAC inhibitors
granted A61PA61P1/16A61P29/00
Quick answer
US patent 8143445 (HDAC inhibitors) held by Lixte Biotechnology, Inc. expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Lixte Biotechnology, Inc.
- Grant date
- Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 49
- CPC classes
- A61P, A61P1/16, A61P29/00, A61P3/10, A61P31/18